Use of inhibitors of heparin-binding epidermal growth factor or inhibitors of its receptors for the preparation of drugs useful for treating myeloma
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Dec 16, 2004
app pub date -
Jul 12, 2004
filing date -
Aug 1, 2001
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The present invention relates to the use of at least one inhibitor of heparin-binding (HB) epidermal growth factor (EGF), or at least one inhibitor of HB-EGF receptors, or ErbB receptors, or at least one inhibitor of associated transduction pathways for the preparation of drugs useful for inducing the apoptosis and/or inhibiting the proliferation of IL-6-dependent plasmocytic tumor cells.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully